| AGM |
Annual general meeting |
| API |
Active pharmaceutical ingredient |
| ARV |
Anti-retroviral |
| BMT |
Tiger Brands Black Managers Trust |
| CNS |
Central Nervous System |
| CSR |
Corporate Social Responsibility |
| EPS |
Earnings per share |
| EVP |
Employee value proposition |
| Executive management |
The Executive Directors |
| FEC |
Forward Exchange Contracts |
| GMP |
Good Manufacturing Practices |
| HCP |
Healthcare Practitioner |
| HD |
Haemodialysis |
| HEPS |
Headline earnings per share |
| HIV |
Human Immunodeficiency virus |
| King IV |
King IV Report on Corporate Governance for South Africa, 2016 |
| LTI |
Long-term incentive |
| Management |
Executive management and senior management |
| MCC |
Medicines Control Council |
| NED |
Non-executive director |
| NHI |
National Health insurance |
| OTC |
Over the counter |
| PBLTIS |
Performance based long-term incentive scheme |
| PD |
Peritoneal dialysis |
| PICS |
Pharmaceutical Inspection Co-operation Scheme |
| POPIA |
Protection of Personal Information Act |
| SAHPRA |
South African Health Products Regulatory Authority |
| Senior management |
The Executive Committee, excluding the Executive Directors |
| SEP |
Single exit price |
| STI |
Short-term incentive |
| TGP |
Total guaranteed pay |
| Variable pay |
STI and LTI |
